205654-37-1
中文名称
205654-37-1
英文名称
Urea, N'-[[2-[2-[(4-chlorophenyl)thio]ethoxy]-3-methoxy-5-[(2S,5S)-tetrahydro-5-(3,4,5-trimethoxyphenyl)-2-furanyl]phenyl]methyl]-N-hydroxy-N-methyl-
CAS
205654-37-1
分子式
C31H37ClN2O8S
分子量
633.15
MOL 文件
205654-37-1.mol
![205654-37-1 结构式](/CAS/20180601/GIF/205654-37-1.gif)
基本信息
中文别名
化合物 T10844 英文别名
Urea, N'-[[2-[2-[(4-chlorophenyl)thio]ethoxy]-3-methoxy-5-[(2S,5S)-tetrahydro-5-(3,4,5-trimethoxyphenyl)-2-furanyl]phenyl]methyl]-N-hydroxy-N-methyl-常见问题列表
生物活性
CMI-392是一种双重 5-lipoxygenese 抑制剂和血小板活化因子 (PAF) 受体拮抗剂,IC50 值分别为100和10 nM。靶点
5-LO 100 nM (IC 50 ) |
PAF 10 nM (IC 50 ) |
体内研究
Topical treatment of CMI-392 in the acute and chronic TPA models result in a significant decrease of ear weight, inflammatory cell infiltration, and histological examination. The ED 50 for PAF-induced mouse hemoconcentration and arachidonic acid-induced mouse ear edema are 2.2 and 1.8 mg/kg, respectively.